MAPT and Alzheimer disease: Consistent with previous studies showing that ageing can predispose neurons to tau pathology by promoting chromatin relaxation and transcriptional instability [14,36], our data suggest that early AD stages may act synergistically with ageing to exacerbate the loss of nuclear AT8, a phenomenon that becomes more pronounced as the disease progresses.